Idenix Pharma (IDIX) Posts Wider than Expected Q4 Loss
Tweet Send to a FriendGet Alerts IDIX Hot Sheet
Price: $4.27 +1.91%
EPS Growth %: +5.6%
Financial Fact:
Total operating expenses: 31.88M
Today's EPS Names:
ANF, DXLG, FL, More
EPS Growth %: +5.6%
Financial Fact:
Total operating expenses: 31.88M
Today's EPS Names:
ANF, DXLG, FL, More
Trade IDIX Now!
Idenix Pharmaceuticals Inc. (NASDAQ: IDIX) reported Q4 loss of $0.22, $0.04 worse than the analyst estimate of ($0.18). Revenue for the quarter came in at $24 million versus the consensus estimate of $6.05 million.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Abercrombie & Fitch Co. (ANF) Misses Q1 EPS by 4c; Guides FY Below Views
- Mentor Graphics Corp (MENT) Tops Q1 EPS by 5c; Guides Q2, FY14
- Hibbett Sports, Inc. (HIBB) Misses Q1 EPS by 7c; Maintains FY Outlook
Create E-mail Alert Related Categories
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
